Advancements in prophylactic and therapeutic nanovaccines

P Bhardwaj, E Bhatia, S Sharma, N Ahamad… - Acta Biomaterialia, 2020 - Elsevier
Vaccines activate suitable immune responses to fight against diseases but can possess
limitations such as compromised efficacy and immunogenic responses, poor stability, and …

Mucoadhesive and thermogelling systems for vaginal drug delivery

CM Caramella, S Rossi, F Ferrari, MC Bonferoni… - Advanced drug delivery …, 2015 - Elsevier
This review focuses on two formulation approaches, mucoadhesion and thermogelling,
intended for prolonging residence time on vaginal mucosa of medical devices or drug …

Recent advances in polymer-based vaginal drug delivery systems

T Osmałek, A Froelich, B Jadach, A Tatarek… - Pharmaceutics, 2021 - mdpi.com
The vagina has been considered a potential drug administration route for centuries. Most of
the currently marketed and investigated vaginal formulations are composed with the use of …

Nanoparticle-based drug delivery to the vagina: a review

LM Ensign, R Cone, J Hanes - Journal of Controlled Release, 2014 - Elsevier
Vaginal drug administration can improve prophylaxis and treatment of many conditions
affecting the female reproductive tract, including sexually transmitted diseases, fungal and …

Proniosomes derived niosomes: recent advancements in drug delivery and targeting

M Khatoon, KU Shah, FU Din, SU Shah… - Drug …, 2017 - Taylor & Francis
Vesicular drug delivery systems have gained wide attention in the field of nanotechnology.
Among them proniosomes become the superior over other vesicular carriers. Proniosomes …

Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art

G Leyva-Gómez, E Piñón-Segundo… - International journal of …, 2018 - mdpi.com
The vagina is a region of administration with a high contact surface to obtain local or
systemic effects. This anatomical area represents special interest for government health …

Polymer-based nanocarriers for vaginal drug delivery

J das Neves, R Nunes, A Machado… - Advanced drug delivery …, 2015 - Elsevier
The vaginal delivery of various drugs is well described and its relevance established in
current medical practice. Alongside recent advances and achievements in the fields of …

Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs

C Cunha-Reis, A Machado, L Barreiros, F Araújo… - Journal of Controlled …, 2016 - Elsevier
Combining two or more antiretroviral drugs in one medical product is an interesting but
challenging strategy for developing topical anti-HIV microbicides. We developed a new …

Combination drug therapy via nanocarriers against infectious diseases

P Walvekar, R Gannimani, T Govender - European Journal of …, 2019 - Elsevier
Current drug therapy against infections is threatening to become obsolete due to the poor
physical, chemical, biological and pharmacokinetic properties of drugs, followed by high risk …

Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?

Ž Vanić, N Škalko-Basnet - European Journal of Pharmaceutical Sciences, 2013 - Elsevier
Nanopharmaceuticals have the potential to revolutionise medical treatment by permitting the
design of more potent, less toxic “smart” therapeutics, ultimately leading to personalised …